6418
K. Nakanishi et al. / Tetrahedron 64 (2008) 6415–6419
4H), 5.03 (dd, 1H, J¼5.0, 10.5 Hz), 7.28–7.40 (m, 3H), 7.48–7.50 (m,
3259, 2979, 1578, 1486, 1230, 733 cmꢀ1; mp: 69.0–71.0 ꢁC; 1H NMR
(CDCl3):
1.25 (t, 3H, J¼6.9 Hz), 1.28 (t, 3H, J¼6.9 Hz), 1.71 (br s, 1H),
4.00–4.11 (m, 4H), 4.99 (d, 1H, J¼11.0 Hz), 7.35–7.38 (m, 2H), 7.49–
7.51 (m, 2H); 13C NMR (CDCl3):
16.32, 16.37, 63.1 (Jcp¼7.6 Hz), 63.5
2H); 31P NMR (CDCl3):
d
21.4; HPLC (Daicel Chiralpak AS, flow rate:
d
1.0 mL/min, hexane/iPrOH¼19/1, UV detection at 254 nm):
tR¼17.2 min (R, major), 22.5 min (S, minor).
d
(Jcp¼6.7 Hz), 70.1 (Jcp¼159.2 Hz), 121.9 (Jcp¼3.81 Hz), 128.7
4.3.2. (R)-Dimethyl 1-hydroxy-1-phenylmethylphosphonate3e
(Jcp¼4.77 Hz), 131.3, 135.8; 31P NMR (CDCl3):
d 20.6; MS (FAB): m/z
TLC: Rf 0.23 (hexane/acetone¼1/1, stained blue with phospho-
121, 185, 305, 307, 323, 325 [MþH]þ; HRMS: calcd for C11H17O4BrP
323.0048 (100), 325.0029(99), found 323.0043; HPLC (Daicel
Chiralpak AS, flow rate: 1.0 mL/min, hexane/iPrOH¼9/1, UV
detection at 254 nm): tR¼11.0 min (major), 14.8 min (minor).
20
molybdic acid/EtOH); [
a
]
þ21.5 (c 0.80, CHCl3) for 28% ee (R).
D
20
[lit.17
[
a
]
D
ꢀ45 (c 0.80, CHCl3) for 90% ee (S)]; mp: 91.0–92.5 ꢁC; 1H
NMR (CDCl3):
d
3.22–3.27 (m, 1H), 3.67 (d, 3H, J¼10.1 Hz), 3.72 (d,
3H, J¼10.5 Hz), 5.06 (dd,1H, J¼5.0,11.0 Hz), 7.31–7.40 (m, 3H), 7.49–
7.50 (m, 2H); 31P NMR (CDCl3):
d
23.5; HPLC (Daicel Chiralpak AS,
4.3.8. Diethyl 1-hydroxy-1-(1-naphthyl)methylphosphonate (2d)20
flow rate: 1.0 mL/min, hexane/iPrOH¼9/1, UV detection at 254 nm):
tR¼15.7 min (R, major), 19.9 min (S, minor).
TLC: Rf 0.13 (hexane/acetone¼2/1, stained blue with phospho-
19
molybdic acid/EtOH); [
a
]
D
þ11.5 (c 1.01, CHCl3) for 9% ee. [lit.20
20
[a
]
þ19.4 (c 1.19, CHCl3) for 35% ee]; mp: 114.0–115.5 ꢁC; 1H NMR
D
4.3.3. (R)-Diisopropyl 1-hydroxy-1-phenylmethylphosphonate17
(CDCl3):
d
1.05 (t, 3H, J¼6.9 Hz), 1.25 (t, 3H, J¼6.9 Hz), 3.32 (dd, 1H,
TLC: Rf 0.57 (hexane/acetone¼1/1, stained blue with phospho-
J¼5.5, 11.5 Hz), 3.72–3.82 (m, 1H), 3.92–4.12 (m, 3H), 5.86 (dd,
1H, J¼5.5, 11.5 Hz), 7.48–7.56 (m, 3H), 7.82–7.88 (m, 3H), 8.10 (d, 1H,
19
molybdic acid/EtOH); [
a]
þ12.2 (c 1.01, CHCl3) for 40% ee (R). [lit.18
D
20
[a
]
D
ꢀ17.3 (c 1.0, CHCl3) for 65% ee (S)]; mp: 85.0–86.5 ꢁC; 1H NMR
J¼8.2 Hz); 31P NMR (CDCl3):
d 21.7; HPLC (Daicel Chiralpak AS, flow
(CDCl3):
d
1.13 (d, 3H, J¼6.0 Hz), 1.24 (d, 3H, J¼6.0 Hz), 1.276 (d, 3H,
rate: 1.0 mL/min, hexane/iPrOH¼9/1, UV detection at 254 nm):
tR¼12.4 min (major), 42.3 min (minor).
J¼6.4 Hz), 1.281 (d, 3H, J¼6.0 Hz), 3.19 (br s, 1H), 4.57–4.67 (m, 2H),
4.96(d,1H, J¼11.0 Hz), 7.28–7.38(m, 3H), 7.48–7.50(m, 2H); 31PNMR
(CDCl3):
d
19.9; HPLC (Daicel Chiralpak AS, flow rate: 1.0 mL/min,
4.3.9. Diethyl 1-hydroxy-(2-naphthyl)methylphosphonate (2e)
hexane/iPrOH¼39/1): tR¼12.1 min (R, major), 14.5 min (S, minor).
TLC: Rf 0.21 (hexane/acetone¼2/1, stained blue with phospho-
22
molybdic acid/EtOH); [
a
]
þ11.9 (c 1.0, CHCl3) for 33% ee (R); IR
D
4.3.4. Di-n-butyl 1-hydroxy-1-phenylmethylphosphonate
(KBr): 3273, 2981, 1630, 1600, 1234, 1016, 762 cmꢀ1; mp: 88.0–
TLC: Rf 0.35 (hexane/acetone¼2/1, stained blue with phospho-
89.0 ꢁC; 1H NMR (CDCl3):
d
1.21 (t, 3H, J¼6.9 Hz), 1.26 (t, 3H,
20
molybdic acid/EtOH); [
a
]
þ8.8 (c 1.05, CHCl3) for 33% ee; IR
J¼6.9 Hz), 3.89–4.18 (m, 5H), 5.20 (dd, 1H, J¼4.1, 11.0 Hz), 7.46–7.50
D
(neat): 3282, 2960, 1454, 1236, 1058, 734 cmꢀ1 1H NMR (CDCl3):
;
(m, 2H), 7.60 (d, 1H, J¼8.7 Hz), 7.82–7.85 (m, 3H), 7.96 (s, 1H); 13C
d
0.87 (t, 3H, J¼7.3 Hz), 0.90 (t, 3H, J¼7.3 Hz), 1.24–1.39 (m, 4H),
NMR (CDCl3):
d
16.31, 16.35, 63.1 (Jcp¼6.7 Hz), 63.4 (Jcp¼7.6 Hz),
1.50–1.63 (m, 4H), 3.34 (dd, 1H, J¼5.0, 10.3 Hz), 3.88–4.11 (m, 4H),
5.02 (dd, 1H, J¼5.0, 11.0 Hz), 7.27–7.38 (m, 3H), 7.47–7.49 (m, 2H);
70.9 (Jcp¼158.3 Hz), 124.9 (Jcp¼3.8 Hz), 126.05, 126.11, 127.6, 127.8,
128.0, 133.0, 134.16, 134.20; 31P NMR (CDCl3):
d 21.4; MS (FAB): m/z
13C NMR (CDCl3):
d
13.8, 18.8 (Jcp¼4.8 Hz), 32.7 (Jcp¼4.8 Hz), 66.8
157, 277, 295 [MþH]þ; HRMS: calcd for C15H20O4P 295.1099, found
295.1100; HPLC (Daicel Chiralpak AS, flow rate: 1.0 mL/min,
hexane/iPrOH¼4/1, UV detection at 254 nm): tR¼8.3 min (major),
9.9 min (minor).
(Jcp¼7.6 Hz), 67.7 (Jcp¼7.6 Hz), 71.0 (Jcp¼158.3 Hz), 127.4 (Jcp
¼
5.7 Hz), 128.1 (Jcp¼3.0 Hz), 128.3, 137.1; 31P NMR (CDCl3):
d 21.3; MS
(FAB): m/z 107, 173, 227, 301 [MþH]þ; HRMS: calcd for C15H26O4P
301.1569, found 301.1588; HPLC (Daicel Chiralpak AS, flow rate:
1.0 mL/min, hexane/iPrOH¼39/1, UV detection at 254 nm):
tR¼12.0 min (major), 16.9 min (minor).
4.3.10. (1R,2E)-Diethyl 1-hydroxy-3-phenylprop-2-enyl-
phosphonate (2f)21
TLC: Rf 0.34 (hexane/acetone¼1/1, stained blue with phospho-
18
4.3.5. (R)-Dibenzyl 1-hydroxy-1-phenylmethylphosphonate19
molybdic acid/EtOH); [
a
]
D
þ7.7 (c 0.92, CHCl3) for 49% ee (R). [lit.20
20
TLC: Rf 0.27 (hexane/acetone¼2/1, stained blue with phospho-
[a
]
þ4.7 (c 0.59, CHCl3) for 41% ee (R)]; mp: 99.0–99.5 ꢁC; 1H NMR
D
18
molybdic acid/EtOH); [
a
]
D
þ0.4 (c 1.01, MeOH) for 8% ee (R). [lit.19
(CDCl3):
d
1.34 (t, 6H, J¼7.1 Hz), 2.66 (dd, 1H, J¼3.6, 5.5 Hz), 4.16–
19
[
a]
ꢀ16.3 (c 1.0, MeOH) for 99% ee (S)]; mp: 103.0–104.0 ꢁC; 1H
4.24 (m, 4H), 4.64–4.70 (m, 1H), 6.32 (ddd, 1H, J¼5.5, 5.7, 16.0 Hz),
NMR (CDCl3):
d
3.33 (dd, 1H, J¼5.0, 9.8 Hz), 4.84–4.97 (m, 4H), 5.07
6.78 (dd, 1H, J¼4.6, 16.0 Hz), 7.25–7.42 (m, 5H); 31P NMR (CDCl3):
(dd, 1H, J¼4.1, 10.3 Hz), 7.19–7.22 (m, 2H), 7.26–7.36 (m, 11H), 7.44–
d 21.9; HPLC (Daicel Chiralpak AS, flow rate: 1.0 mL/min,
7.46 (m, 1H); 31P NMR (CDCl3):
d
22.1; HPLC (Daicel Chiralpak AS,
hexane/iPrOH¼9/1, UV detection at 254 nm): tR¼14.0 min (R,
major), 23.0 min (S, minor).
flow rate: 1.0 mL/min, hexane/iPrOH¼4/1, UV detection at 254 nm):
tR¼9.2 min (R, major), 15.5 min (S, minor).
4.3.11. (R)-Diethyl 1-hydroxy-3-phenylpropylphosphonate (2g)20
4.3.6. (R)-Diethyl 1-hydroxy-1-(4-methoxyphenyl)-
TLC: Rf 0.39 (hexane/acetone¼1/1, stained blue with phospho-
20
methylphosphonate (2b)20
molybdic acid/EtOH); [
a
]
ꢀ3.7 (c 1.0, CHCl3) for 17% ee; 1H NMR
D
TLC: Rf 0.34 (hexane/acetone¼1/1, stained blue with phospho-
(CDCl3): d 1.30–1.35 (m, 6H), 1.95–2.14 (m, 2H), 2.67–2.78 (m, 2H),
18
molybdic acid/EtOH); [
a
]
D
þ14.1 (c 1.01, CHCl3) for 40% ee (R). [lit.20
2.92–2.99 (m, 1H), 3.82–3.89 (m, 1H), 4.12–4.19 (m, 4H), 7.18–7.31
20
[
a]
þ29.8 (c 1.49, CHCl3) for 74% ee (R)]; mp: 119.0–120.0 ꢁC; 1H
(m, 5H); 13C NMR (CDCl3):
d
16.4 (d, Jcp¼4.8 Hz),16.5 (d, Jcp¼4.8 Hz),
D
NMR (CDCl3):
d
1.23 (t, 3H, J¼6.9 Hz), 1.29 (t, 3H, J¼6.9 Hz), 2.68–
31.6 (d, Jcp¼14.3 Hz), 32.9, 62.5 (d, Jcp¼7.7 Hz), 62.8 (d, Jcp¼7.7 Hz),
2.74 (m, 1H), 3.82 (s, 3H), 3.92–4.11 (m, 4H), 4.95 (dd, 1H, J¼5.0,
66.8 (d, Jcp¼160.2 Hz), 125.9, 128.4, 128.6, 141.3; 31P NMR (CDCl3):
10.1 Hz), 6.91 (d, 2H, J¼8.2 Hz), 7.26–7.43 (m, 2H); 31P NMR (CDCl3):
d
25.3. The enantiomeric excess was determined by 31P NMR
d
21.8; HPLC (Daicel Chiralpak AS, flow rate: 1.0 mL/min,
analysis of a solution of the phosphonate (5 mg) and quinine
(40 mg) in CDCl3 (0.6 mL).15
hexane/iPrOH¼4/1, UV detection at 254 nm): tR¼11.0 min (R, ma-
jor), 14.7 min (S, minor).
4.3.12. Diethyl 1-hydroxy-1-cyclohexylmethylphosphonate (2h)22
4.3.7. Diethyl 1-hydroxy-1-(4-bromophenyl)methyl-
phosphonate (2c)
TLC: Rf 0.35 (hexane/acetone¼2/1, stained blue with phospho-
21
molybdic acid/EtOH); [
a
]
ꢀ1.5 (c 1.16, CHCl3) for 23% ee; 1H NMR
D
TLC: Rf 0.48 (hexane/acetone¼1/1, stained blue with phospho-
(CDCl3):
d
1.35 (t, 3H, J¼6.9 Hz), 1.35 (t, 3H, J¼6.9 Hz), 1.09–1.35 (m,
22
molybdic acid/EtOH); [
a
]
þ7.2 (c 0.99, CHCl3) for 22% ee; IR (KBr):
5H), 1.66 (br d, 1H, J¼11.4 Hz), 1.72–1.82 (m, 4H), 2.00 (br d, 1H,
D